Cell and Organ Transplantology. 2023; 11(2):96-103.
DOI: 10.22494/cot.v11i2.155
The effects of human umbilical cord-derived multipotent mesenchymal stromal cells transplantation in mice of different strains with an experimental model of parkinsonism
Labunets I.1,2
, Panteleymonova T.1,2, Kyryk V.1,2, Toporova O.1,3, Pikus P.1,3, Litoschenko Z.1,2
- 1Institute of Genetic and Regenerative Medicine, M. D. Strazhesko National Scientific Center of Cardiology, Clinical and Regenerative Medicine, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
- 2D. F. Chebotarev State Institute of Gerontology, National Academy of Medical Sciences of Ukraine, Kyiv, Ukraine
- 3Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, Kyiv, Ukraine
Abstract
One of the promising directions of cell therapy for Parkinson’s disease/parkinsonism is the transplantation of human umbilical cord-derived multipotent mesenchymal stromal/stem cells (hUC-MMSCs), the effectiveness of which may depend on the recipient’s genotype.
Purpose – to compare the effect of transplanted hUC-MMSCs on behavior, number of T-lymphocytes and macrophages in the brain and lymphoid organs of mice of different strains with a toxin-induced model of parkinsonism.
Methods. Adult (6-7-month-old) male mice of FVB/N (genotype H-2q) and 129/Sv (genotype H-2b) strains were administered the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) at a dose of 30 mg/kg (control group), and after 7 days, hUC-MMSCs at a dose of 500,000 cells were transplanted into the tail vein. Behavioral reactions were assessed in the “open field”, rigidity and rotarod tests. The relative content of T-lymphocytes and activated macrophages in the brain, as well as the weight of lymphoid organs were determined.
Results. Under the influence of MPTP, the number of rearings, hole-peeking, body length and step length decreased; the number of boluses increased in FVB/N and 129/Sv mice, and the number of crossed squares in the open field test also decreased in 129/Sv mice. In the brain of mice of both strains, the content of activated macrophages increased and, in FVB/N mice, the number of T-lymphocytes increased too. The thymus weight decreased in mice of both strains, while the spleen weight decreased only in 129/Sv mice. Under the influence of hUC-MMSCs, the motor activity improved mainly in FVB/N mice, while the emotional activity improved in 129/Sv mice. The manifestations of rigidity decreased in mice of both strains. The content of T-lymphocytes and activated macrophages in the brain of mice from both strains, as well as the thymus weight, corresponded to the values of intact animals. The transplantation of hUC-MMSCs contributed to the survival of FVB/N and 129/Sv mice with the MPTP-induced parkinsonism model.
Conclusion. The manifestations of behavioral disorders, changes in the content of T-lymphocytes and activated macrophages in the brain, the weight of lymphoid organs in mice with the MPTP-induced model of parkinsonism, as well as the positive effects of transplanted hUC-MMSCs in such animals largely depend on their H-2 genotype (analogous to the HLA system in humans). The results can provide the basis for the development of personalized cell therapy for parkinsonism using hUC-MMSCs.
Key words: human umbilical cord-derived multipotent mesenchymal stromal cells; parkinsonism; behavioral reactions; brain T-lymphocytes and macrophages; thymus; spleen
Full Text PDF
| 1. Sulzev D, Surmeiter DJ. Neuronal vulnerability, pathogenests and Parkinson’s disease. Mov Disord. 2013; 28:715-724. https://doi.org/10.1002/mds.25095 PMid:22791686 PMCid:PMC3578396 |
||||
| 2. Wang Q, Liu Y, Zhou J. Neuroinflammation in Parkinson’s disease and its potential as therapeutic target. Translat Neurodegenerat. 2015. 4(19). https://doi.org/10.1186/s40035-015-0042-0 PMid:26464797 PMCid:PMC4603346 |
||||
| 3. Guo J-D, Zhao X, Li Y., Li G-R, Liu X-L. Damage to dopaminergic neurons by oxidative stress in Parkinson’s disease (Review). Int J Mol Med. 2018; 41:1817-1825. https://doi.org/10.3892/ijmm.2018.3406 |
||||
| 4. Appel H, Beers R, Henkel S. The T cell-microglial dialogue in Parkinson’s disease and amyotrophic lateral sclerosis: are we listening? Trends Immunol. 2010; 31(1):7-17. https://doi.org/10.1016/j.it.2009.09.003 PMid:19879804 PMCid:PMC4126423 |
||||
| 5. Kannarkat GT, Cook DA, Lee JK, Chang J, Chung J, Sandy E, et al. Common genetic variant association with altered HLA expression synergy with pyrethroid exposure, and risk for Parkinson’s disease: an observational and case control study. Parkinson’s disease. 2015. https://doi.org/10.1038/npjparkd.2015.2 PMid:27148593 PMCid:PMC4853162 |
||||
| 6. Yue H, Han W, Sheng L. Associated of proinflammatory cytokines gene polymorphisms with Alzheimer’s disease susceptibility in the Han Chinese population. Int J Clin Exp Med. 2017; 10(3):5422-5428. Available from: https://e-century.us/files/ijcem/10/3/ijcem0023397.pdf | ||||
| 7. Dawson TM, Golde T, Lagier-Tourenne CL. Animal models of neurodegenerative diseases. Nat Neurosci. 2018; 21(10):370-1379. https://doi.org/10.1038/s41593-018-0236-8 PMid:30250265 PMCid:PMC6615039 |
||||
| 8. Fisher EM, Bannerman DM. Mouse models of neurodegeneration: know your question, know your mice. Sci Transl Med. 2019; 11. https://doi.org/10.1126/scitranslmed.aaq1818 PMid:31118292 |
||||
| 9. Seeger DR, Murphy EJ. Mouse strain impacts fatty acid uptake and trafficking in liver, heart and brain: a comparison of C57BL/6 and Swiss Webster mice. Lipids. 2016; 51(5):549-560. https://doi.org/10.1007/s11745-015-4117-6 PMid:26797754 |
||||
| 10. Matsio K, Watanabe Т, Takenaka А. Effect of dietary vitamin E on oxidative stress-related gene-mediated differences in anxiety-like behavior in inbred strains of mice. Physiol Behav. 2019; 207:64-72. https://doi.org/10.1016/j.physbeh.2019.04.026 PMid:31059718 |
||||
| 11. Li Zh, Cheung H-H. Stem cell-based therapies for Parkinson desease. Int J Mol Sci. 2020; 21. https://doi.org/10.3390/ijms21218060 PMid:33137927 PMCid:PMC7663462 |
||||
| 12. Sugaya K, Vaidya M. Stem cell therapy for neurodegenerative disease. AEMB. 2018; 1056:61-84. https://doi.org/10.1007/978-3-319-74470-4_5 PMid:29754175 |
||||
| 13. Konala VB, Mamidi MK, Bhonde R, Das AK, Pochampally R, Pal R. The current landscape of the mesenchymal stromal cell secretome. Cytotherapy. 2016; 18:13-24. https://doi.org/10.1016/j.jcyt.2015.10.008 PMid:26631828 PMCid:PMC4924535 |
||||
| 14. Zachar L, Bacenlova D, Rosocher I. Activation, homing and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res. 2016; 9:231-240. https://doi.org/10.2147/JIR.S121994 PMid:28008279 PMCid:PMC5170601 |
||||
| 15. Wojtas E, Zachwieja A, Zwyrzykowska A, Kupczynski R, Marycz K. The application of mesenchymal progenitor stem cells in the reduction of oxidative stress in animals. Turk J Biol. 2017; 41:12-19. https://doi.org/10.3906/biy-1603-13 |
||||
| 16. Laroni A, Kerlego de Rosbo N, Uccelli A. Mesenchymal stem cells for the treatment of neurological diseases: immunoregulation beyond neuroprotection. Immunology letter. 2015; 168:183-190. https://doi.org/10.1016/j.imlet.2015.08.007 PMid:26296458 |
||||
| 17. Can A, Celikkan FT, Cinar O. Umbilical cord mesenchymal stromal cell transplantation: a systemic analysis of clinical trials. Cytotherapy. 2017; 19(12):1351-1382. https://doi.org/10.1016/j.jcyt.2017.08.004 PMid:28964742 |
||||
| 18. Maslova OO, Shyvalova NS, Sukhorada OM, Zkukova SM, Deryabina OG, Makarenko MV, et al. Heterogeneity of umbilical cords as a source for MSC. Dataset Papers in biology. 2013. https://doi.org/10.7167/2013/370103 |
||||
| 19. ElOmar R, Beroud J, Stoltz JF, Menu P, Velot E, Decot V. Umbilical cord mesenchymal stem cells-based therapies? Part B Rev. 2014; 20(5):523-544. https://doi.org/10.1089/ten.teb.2013.0664 PMid:24552279 |
||||
| 20. Putra A, Ridwan ВR, Putridewi AI, Kustiyah AR, Wirastuti K, Sadyah NA, et al. The role of TNF-alpha induced MSCs on suppressive inflammation by increasing TGF-beta and IL-10. J Med Sci. 2018; 6(10):1779-1783. https://doi.org/10.3889/oamjms.2018.404 PMid:30455748 PMCid:PMC6236029 |
||||
| 21. Hsieh JY, Fu YS, Chang SJ, Tsuang YH, Wang HW. Functional module analysis reveals differential 0steogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton’s jelly of the umbilical cord. Stem Cells Dev. 2010; 19:1895-1910. https://doi.org/10.1089/scd.2009.0485 PMid:20367285 |
||||
| 22. Li X, Bai J, Ji X, Li R, Xuan Y, Wang Y. Comprehensive characterization of four different populations of human mesenchymal stem cells as regards their immune properties, proliferation and differentiation. Int J Mol Med. 2014; 34(3):695-704. https://doi.org/10.3892/ijmm.2014.1821 PMid:24970492 PMCid:PMC4121354 |
||||
| 23. Ooi YY, Rahmat Z, Jose Sh, Ramasamy R, Vidyadaran Sh. Immunophenotype and differentiation capacity of bone marrow-derived mesenchymal stem cells from CBA/Ca, ICR and Balb/c mice. World J Stem Cells. 2013; 5(1):34-42. https://doi.org/10.4252/wjsc.v5.i1.34 PMid:23362438 PMCid:PMC3557349 |
||||
| 24. Choi EW, Shin IS, Park SY, Yoon EJ, Kang SK, Hong SH. Characteristics of mouse adipose tissue-derived stem cells and therapeutic comparisons between syngeneic and allogeneic adipose tissue-derived stem cells transplantation in exp. autoimmune thyroidit. Cell transplantation. 2014; 23:873-887. https://doi.org/10.3727/096368913X664586 PMid:23485102 |
||||
| 25. Cunpa FF, Martins L, Martin PM, Stilhano RS, Han SW. A comparison of the reparative and angiogenic properties of mesenchymal stem cells derived from the bone marrow of Balb/c and C57Bl/6 mice in a model of limb ischemia. Stem Cell Res Ther. 2013; 4:86. https://doi.org/10.1186/scrt245 PMid:23890057 PMCid:PMC3856613 |
||||
| 26. Eltokhi A, Kurpiers В, Pitzer С. Behavioral tests assessing neuropsychiatric phenotypes in adolescent mice reveal strain- and sex specific effects. Sci Rep. 2020; 10(11263). https://doi.org/10.1038/s41598-020-67758-0 PMid:32647155 PMCid:PMC7347854 |
||||
| 27. Labunets IF, Utko NA, Savosko S, Panteleymonova TN, Butenko GM. Changes in nigral neuronal structure, indices of antioxidant protection of the brain and behavior in mice of different age with MPTP parkinsonism model. International neurological journal. 2020; 16(3):7-15. https://doi.org/10.22141/2224-0713.16.3.2020.203444 |
||||
| 28. Kim JWh, Nam SM, Yoo DY, Jung HY, Hwang IK, Seong JK, et al. Strain-specific differential expression of astrocytes and microglia in the mouse hippocampus. Brain Behav. 2018; 8:e00961. https://doi.org/10.1002/brb3.961 PMid:29761014 PMCid:PMC5943717 |
||||
| 29. Zhang XS, Geng WS, Jia JJ. Neurotoxin-induced animal models of Parkinson disease: pathogenic mechanism and assessment. ASN Neuro. 2018; 10(1). https://doi.org/10.1177/1759091418777438 PMid:29809058 PMCid:PMC5977437 |
||||
| 30. Tsymbaliuk VI, Velychko OM, Pichkur OL, Verbovska SA, Shuvalova NS, Toporova ОК, et al. Effects of Warton’s jelly humans mesenchymal stem cells transfected with plasmid containing il-10 gene to the behavioral response in rats with experimental allergic encephalomyelitis. Сell Organ Transpl. 2015; 3(2):139-143. https://doi.org/10.22494/COT.V3I2.14 |
||||
| 31. Alam G, Edler M, Burchfield Sh, Richardson JR. Single Low Doses of MPTP Decrease Tyrosine Hydroxylase Expression in the Absence of Overt Neuron Loss. Neurotoxicology. 2017; 60:99-106. https://doi.org/10.1016/j.neuro.2017.03.008 PMid:28377118 PMCid:PMC5499677 |
||||
| 32. Fernagut PO, Diguet E, Labattu B, Tison F. A simple method to measure stride length as an index of nigrostrial dysfunction in mice. J. Neurosci. Methods. 2002; 113(2):123-130. https://doi.org/10.1016/S0165-0270(01)00485-X PMid:11772434 |
||||
| 33. Huang L, Xiao D, Sun H, Qu Yi, Su X. Behavioral tests for evaluating the characteristics of brain diseases in rodent models: Optimal choices for improved outcomes (Review). Mol.med.reports. 2022; 25(5). https://doi.org/10.3892/mmr.2022.12699 PMid:35348193 |
||||
| 34. Labunets IF, Panteleymonova TM, Utko NO, Kyryk VM, Savosko SI, Litochenko ZL.Changes in the number of macrophages, T-lymphocytes, activity of antioxidant enzymes in the brain, behavior and structure of the central nervous system neurons in adult and aging mice of different strains with the MPTP-induced model of parkinsonism. Int Neurol J (Ukraine). 2023; 19(4):119-128. https://doi.org/10.22141/2224-0713.19.4.2023.1010 |
||||
| 35. Jagmag SA, Tripathi N, Shukla SD, Maithis S, Khurana S. Evaluation of models of Parkinson’s disease. Frontiers in Neurosciences. 2016; 9:503. https://doi.org/10.3389/fnins.2015.00503 PMid:26834536 PMCid:PMC4718050 |
||||
| 36. Gonzalez H, Pacheco R. T-cell-mediated regulation of neuroinflammation involved in neurodegenerative diseases. J Neuroinflammation. 2014; 11:201. https://doi.org/10.1186/s12974-014-0201-8 PMid:25441979 PMCid:PMC4258012 |
||||
| 37. Labunets I, Rodnichenko A, Savosko S, Pivneva T. Reaction of different cell types of the brain on neurotoxin cuprizone and hormone melatonin treatment in young and aging mice. Front Cell Neurosci. 2023; 17:1131130. https://doi.org/10.3389/fncel.2023.1131130 PMid:37153635 PMCid:PMC10157497 |
||||
| 38. Rodriguez-Cruz A, Vesin D, Ramon-Luing L, ZunigaJ, Quesniaux VJ, Ryffel B, et al. CD3+ macrophages deliver proinflammatory cytokines by a CD3- and transmembrane TNF-dependent pathway and are increased at the BCG-infectionsite. Front. Immunol. 2019; 10. https://doi.org/10.3389/fimmu.2019.02550 PMid:31787969 PMCid:PMC6855269 |
||||
| 39. Kim HAh, Whittle SC, Lee S, Chu HX, Zhang ShR, Wei Z, et al. Brain immune cell composition and functional outcome after cerebral ischemia: comparison of two mouse strains. Front Cell Neurosci. 2014; 8. https://doi.org/10.3389/fncel.2014.00365 |
||||
| 40. Csaba G. The immunoendocrine thymus as a pacemarker of lifespan. Acta Microbiol Immunol Hung. 2016; 63:139-158. https://doi.org/10.1556/030.63.2016.2.1 PMid:27352969 |
||||
| 41. Bieganowska K, Czlonkowska A, Bidzinski A, Mierzewska H, Korlak J. Immunological changes in the MPTP-induced Parkinson’s disease mouse model. J Neuroimmunol. 1993; 42(1):33-37. https://doi.org/10.1016/0165-5728(93)90209-H PMid:8423206 |
||||
| 42. Labunets IF, Utko NA, Toporova ОK. Effects of multipotent mesenchymal stromal cells of the human umbilical cord and their combination with melatonin in adult and aging mice with a toxic cuprizone model of demyelination Advances in Gerontology. 2021; 11(2):173-180. https://doi.org/10.1134/S2079057021020077 |
||||
| 43. Labunets I, Utko N, Panteleymonova T, Kyryk V, Kharkevych Yu, Rodnichenko A, et al. Effects of transplanted adipose-derived multipotent mesenchymal stromal cells from mice of different age or from aging donors in combination with melatonin at experimental parkinsonism. Сell Organ Transpl. 2022; 10(1):18-24. https://doi.org/10.22494/cot.v10i1.134 |
||||
| 44. Labunets IF, Utko NA, Toporova OK, Savosko SI, Pokholenko I, Panteleymonova TN, et al. Melatonin and fibroblast growth factor-2 potentiate the effects of human umbilical cord multipotent mesenchymal stromal cells in mice with cuprizone-induced demyelination. Biopolym Cell. 2021; 37:369-378. https://doi.org/10.7124/bc.000A62 |
||||
| 45. Konovalov S, Moroz V, Deryabina O, Shuvalova N, Tochylovsky A, Klymenko P, et al. The effect of mesenchymal stromal cells of different origin on morphological parameters in the somatosensory cortex of rats with acute cerebral ischemia. Cell Organ Transpl. 2023; 11(1):46-52. https://doi.org/10.22494/cot.v11i1.149 |
||||
| 46. Zhang L, Wang LM, Chen WW, Ma Z, Han X, Liu CM, et al. Neural differentiation of human Wharton’s jelly-derived mesenchymal stem cells improves the recovery of neurological function after transplantation in ischemic stroke rats. Neural Regen Res. 2017; 12(7):1103-1110. https://doi.org/10.4103/1673-5374.211189 PMid:28852392 PMCid:PMC5558489 |
||||
| 47. Angeloni C, Gatti M, Prata C, Hrelia S, Maraldi T. Role of mesenchymal stem cells in counteracting oxidative stress-related neurodegeneration. Int J Mol Sci. 2020; 21:3299. https://doi.org/10.3390/ijms21093299 PMid:32392722 PMCid:PMC7246730 |
||||
| 48. Lukhmus O, Koval L, Voytenko L, Uspenska K, Komisarenko S, Deryabina O, et al. Intravenously injected mesenchymal stem cells penetrate the brain and treat inflammation-induced brain damage and memory impairment in mice. Front Pharmacol. 2019; 10. https://doi.org/10.3389/fphar.2019.00355 PMid:31057400 PMCid:PMC6479176 |
||||
| 49. Mukai T, Mon Y, Shimazu T, Takahashi A, Tsunoda H, Yamaquchi S, et al. Intravenous injection of umbilical cord-derived mesenchymal stromal cells attenuates reactive gliosis and hypomyelination in neonatal intraventricular hemorrhage model. Neuroscience. 2017; 355:175-187. https://doi.org/10.1016/j.neuroscience.2017.05.006 PMid:28504197 |
||||
| 50. Praet J, Guglielmetti C, Berneman Z. Cellular and molecular neuropathology of the cuprizone mouse model: clinical relevance for multiple sclerosis. J Neubiorev. 2014; 47:485-505. https://doi.org/10.1016/j.neubiorev.2014.10.004 PMid:25445182 |
||||
| 51. Dabrowski FA, Burdzinska A, Kulesza A, Sladowska A, Zolocinska A, Gala K, et al. Comparison of the paracrine activity of mesenchymal stem cells derived from umbilical cord, amniotic membrane and adipose tissue. J Obstet Gynaecol Res. 2017; 43(11):1758-1768. https://doi.org/10.1111/jog.13432 PMid:28707770 |
||||
| 52. Muller L, Tunger A, Wobus M, vonBonin M, Towers R, Borhouser M, et al. Immunonodulatory propertiers of mesenhymal stronal cells: an update. Front Cell Dev Biol. 2021; 9:637725. https://doi.org/10.3389/fcell.2021.637725 PMid:33634139 PMCid:PMC7900158 |
||||
| 53. Li TS, Shi H, Wang L, Yan C. Effect of Bone Marrow Mesenchymal Stem Cells on Satellite Cell Proliferation and Apoptosis in Immobilization-Induced Muscle Atrophy in Rats. Med Sci Monit. 2016; 22. https://doi.org/10.12659/MSM.898137 PMid:27898654 PMCid:PMC5132424 |
||||
Labunets I, Panteleymonova T, Kyryk V, Toporova O, Pikus P, Litoschenko Z. The effects of human umbilical cord-derived multipotent mesenchymal stromal cells transplantation in mice of different strains with an experimental model of parkinsonism. Cell Organ Transpl. 2023; 11(2):96-103. Available from: https://doi.org/10.22494/cot.v11i2.155
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.